SEC investigates CSX's accounting
US railroad CSX disclosed today in a 10-Q filing lodged with the Securities and Exchange ...
FDX: ABOUT USPS PRIVATISATIONFDX: CCO VIEWFDX: LOWER GUIDANCE FDX: DISRUPTING AIR FREIGHTFDX: FOCUS ON KEY VERTICALFDX: LTL OUTLOOKGXO: NEW LOW LINE: NEW LOW FDX: INDUSTRIAL WOESFDX: HEALTH CHECKFDX: TRADING UPDATEWMT: GREEN WOESFDX: FREIGHT BREAK-UPFDX: WAITING FOR THE SPINHON: BREAK-UP ALLUREDSV: BREACHING SUPPORTVW: BOLT-ON DEALAMZN: TOP PICK
FDX: ABOUT USPS PRIVATISATIONFDX: CCO VIEWFDX: LOWER GUIDANCE FDX: DISRUPTING AIR FREIGHTFDX: FOCUS ON KEY VERTICALFDX: LTL OUTLOOKGXO: NEW LOW LINE: NEW LOW FDX: INDUSTRIAL WOESFDX: HEALTH CHECKFDX: TRADING UPDATEWMT: GREEN WOESFDX: FREIGHT BREAK-UPFDX: WAITING FOR THE SPINHON: BREAK-UP ALLUREDSV: BREACHING SUPPORTVW: BOLT-ON DEALAMZN: TOP PICK
SEEKING ALPHA reports:
– A coronavirus vaccine from Moderna (NASDAQ:MRNA) may shortly join a jab from Pfizer in being distributed across the country, with the FDA to decide on emergency use as early as Friday.
– As soon as it gets the green light, the federal government plans to ship just under 6M initial doses, which is more than double the 2.9M shipped by Pfizer this week.
– Distribution will also be more widespread. Medical supply company McKesson (NYSE:MCK) will obtain the doses from Moderna for packaging and distribution to 3,285 sites nationwide, five times more than…
To read the full post, please click here.
Comment on this article